MicroRNA Regulation in T Cell Immunology

MicroRNAs are short non-coding RNA molecules that fine-tune gene expression by repressing target messenger RNAs. Within T lymphocytes, microRNAs orchestrate key stages of development, activation, differentiation and effector function. During thymic maturation, distinct microRNA signatures guide lineage commitment into CD4+ helper, CD8+ cytotoxic and regulatory T cell subsets. In the periphery, microRNAs adjust sensitivity to antigen presentation by modulating T cell receptor signalling thresholds and downstream cytokine programmes. Dynamic remodelling of microRNA profiles underpins the transition from naïve to effector and memory states, influencing proliferation, survival and homoeostatic maintenance. In regulatory T cells, specific microRNAs impose epigenetic control over transcription factors and cytokine receptors, shaping immunosuppressive capacity. Conversely, in inflammatory or tumour settings, aberrant microRNA expression can skew T cell responses towards exhaustion or dysfunction, compromising immunity. Exploiting microRNA networks offers routes to enhance vaccine efficacy, to reinvigorate anti-tumour T cells or to restore tolerance in autoimmunity. Interventions range from synthetic antagomirs and mimics to targeted nanoparticle delivery, illustrating the global significance of microRNA regulation for immune health and disease intervention.

Research from Nature Portfolio

Recent studies have revealed that microRNA-31 acts as a critical brake on the induction of peripherally derived regulatory T cells. Following T cell receptor engagement and cytokine cues, microRNA-31 is upregulated and directly targets the retinoic acid-inducible protein Gprc5a. By suppressing Gprc5a, microRNA-31 limits regulatory T cell generation and exacerbates autoimmune neuroinflammation. Genetic deletion of microRNA-31 enhances regulatory T cell formation, restores Gprc5a expression and attenuates experimental autoimmune encephalomyelitis. These findings uncover an epigenetic circuit in which a single microRNA modulates T cell plasticity and identifies microRNA-31 as a potential target to bolster regulatory T cell-mediated control of autoimmunity.

MicroRNA Regulation in T Cell Immunology publication trend

The graph below shows the total number of articles in microrna regulation in t cell immunology across all publications each year (not limited to Nature Index journals).

Technical terms

MicroRNA: Small non-coding RNA that represses gene expression by binding target mRNAs.

T Cell Receptor (TCR): Surface complex that recognises antigen-presented peptides and initiates T cell activation.

Regulatory T Cell (Treg): Subset of CD4+ T cells that suppresses immune responses to maintain tolerance.

Dendritic Cell (DC): Antigen-presenting cell that primes naïve T cells and modulates immune activation.

Immunogenic Cell Death: Form of cell death that releases danger signals and enhances antigen presentation.

Tumour Microenvironment (TME): Local cellular and molecular milieu within a tumour that influences immune activity.

References

1. The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. Frontiers in Immunology (2024).
2. miRNA Profiling of Naïve, Effector and Memory CD8 T Cells. PLOS ONE (2007).
3. MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. Nature Communications (2015).
4. Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death. Theranostics (2024).
5. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy. Journal of Nanobiotechnology (2024).